Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma
<p dir="ltr">Multiple myeloma (MM) is a hematologic disorder of B lymphocytes characterized by the accumulation of malignant plasma cells (PCs) in the bone marrow. The altered plasma cells overproduce abnormal monoclonal immunoglobulins and also stimulate osteoclasts. The host’s immu...
Saved in:
| Main Author: | Sabah Akhtar (5809925) (author) |
|---|---|
| Other Authors: | Tayyiba A. Ali (18131836) (author), Ammara Faiyaz (20280333) (author), Omar S. Khan (20280336) (author), Syed Shadab Raza (5775911) (author), Michal Kulinski (3520070) (author), Halima El Omri (6595529) (author), Ajaz A. Bhat (12984701) (author), Shahab Uddin (154400) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling
by: Sabah Akhtar (5809925)
Published: (2019) -
Establishment of a clinical pharmacist-led multiple myeloma clinic with collaborative prescribing model at the national center for cancer care and research in Qatar
by: Rola Ghasoub (16555851)
Published: (2024) -
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
by: Kalyani Patil (2679424)
Published: (2022) -
Neosetophomone B induces apoptosis in multiple myeloma cells via targeting of AKT/SKP2 signaling pathway
by: Shilpa Kuttikrishnan (3520079)
Published: (2023) -
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
by: Gunjan Dagar (9339276)
Published: (2023)